Increase in th17 and t-reg lymphocytes and decrease of il22 correlate with the recovery phase of acute eae in rat

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Almolda, Beatriz ^a   Costa, Manuela ^b   Montoya, Maria ^c   González, Berta ^a   Castellano, Bernardo ^a  

^a INSTITUT DE NEUROCIÈNCIES   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c CENTRE DE RECERCA EN SANITAT ANIMAL CRESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 21; INTERLEUKIN 22; CD3 ANTIGEN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; CYTOKINE RELEASE; CYTOKINE RESPONSE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; NONHUMAN; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REGULATORY T LYMPHOCYTE; SPINAL CORD; T LYMPHOCYTE SUBPOPULATION; TH17 CELL; ACUTE DISEASE; ANIMAL; GENE EXPRESSION REGULATION; IMMUNOLOGY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; TH1 CELL;

RATTUS;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD3; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION; INTERLEUKINS; PHENOTYPE; RATS; RECOVERY OF FUNCTION; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 80455131298     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027473     Document Type: Article

References (53)

1. MacPhee IA, Mason DW, (1990) Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease. J Neuroimmunol 27: 9-19.
2. Namikawa T, Kunishita T, Tabira T, (1986) Modulation of experimental allergic encephalomyelitis (EAE): suppression of active reinduction of EAE in rats recovered from passively transferred disease. J Neuroimmunol 12: 235-245.
3. Almolda B, Gonzalez B, Castellano B, (2010) Activated microglial cells acquire an immature dendritic cell phenotype and may terminate the immune response in an acute model of EAE. J Neuroimmunol 223: 39-54.
4. Almolda B, Costa M, Montoya M, Gonzalez B, Castellano B, (2009) CD4 microglial expression correlates with spontaneous clinical improvement in the acute Lewis rat EAE model. J Neuroimmunol 209: 65-80.
5. Kuchroo VK, Anderson AC, Waldner H, Munder M, Bettelli E, et al. (2002) T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu Rev Immunol 20: 101-123.
6. Gold R, Linington C, Lassmann H, (2006) Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129: 1953-1971.
7. Reinhardt RL, Kang SJ, Liang HE, Locksley RM, (2006) T helper cell effector fates-who, how and where? Curr Opin Immunol 18: 271-277.
8. Dittel BN, (2008) CD4 T cells: Balancing the coming and going of autoimmune-mediated inflammation in the CNS. Brain Behav Immun 22: 421-430.
9. Takatori H, Kanno Y, Chen Z, O'Shea JJ, (2008) New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol 18: 533-541.
10. Harrington LE, Mangan PR, Weaver CT, (2006) Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr Opin Immunol 18: 349-356.
11. Aranami T, Yamamura T, (2008) Th17 Cells and autoimmune encephalomyelitis (EAE/MS). Allergol Int 57: 115-120.
12. Jager A, Dardalhon V, Sobel RA, Bettelli E, Kuchroo VK, (2009) Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J Immunol 183: 7169-7177.
13. Korn T, Anderson AC, Bettelli E, Oukka M, (2007) The dynamics of effector T cells and Foxp3+ regulatory T cells in the promotion and regulation of autoimmune encephalomyelitis. J Neuroimmunol 191: 51-60.
14. Kohm AP, McMahon JS, Podojil JR, Begolka WS, DeGutes M, et al. (2006) Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J Immunol 176: 3301-3305.
15. McGeachy MJ, Stephens LA, Anderton SM, (2005) Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4+CD25+ regulatory cells within the central nervous system. J Immunol 175: 3025-3032.
16. Barten DM, Clark RB, Ruddle NH, (1995) Presence of T cells with activated and memory phenotypes in inflammatory spinal cord lesions. J Immunol 155: 5409-5418.
17. Sun D, Wilson DB, Cao L, Whitaker JN, (1998) The role of regulatory T cells in Lewis rats resistant to EAE. J Neuroimmunol 81: 177-183.
18. Flugel A, Berkowicz T, Ritter T, Labeur M, Jenne DE, et al. (2001) Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14: 547-560.
19. Conant SB, Swanborg RH, (2004) Autoreactive T cells persist in rats protected against experimental autoimmune encephalomyelitis and can be activated through stimulation of innate immunity. J Immunol 172: 5322-5328.
20. Kawakami N, Nagerl UV, Odoardi F, Bonhoeffer T, Wekerle H, et al. (2005) Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion. J Exp Med 201: 1805-1814.
21. Sonobe Y, Jin S, Wang J, Kawanokuchi J, Takeuchi H, et al. (2007) Chronological changes of CD4(+) and CD8(+) T cell subsets in the experimental autoimmune encephalomyelitis, a mouse model of multiple sclerosis. Tohoku J Exp Med 213: 329-339.
22. Rigolio R, Biffi A, Oggioni N, Cavaletti G, (2008) Actively induced EAE in Lewis rats: characterization of spleen and spinal cord infiltrating lymphocytes by flow cytometry during the course of the disease. J Neuroimmunol 199: 67-74.
23. Siffrin V, Brandt AU, Radbruch H, Herz J, Boldakowa N, et al. (2009) Differential immune cell dynamics in the CNS cause CD4+ T cell compartmentalization. Brain 132: 1247-1258.
24. Ben-Nun A, Wekerle H, Cohen IR, (1981) The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis. Eur J Immunol 11: 195-199.
25. van der Laan LJ, van der Goes A, Wauben MH, Ruuls SR, Dopp EA, et al. (2002) Beneficial effect of modified peptide inhibitor of alpha4 integrins on experimental allergic encephalomyelitis in Lewis rats. J Neurosci Res 67: 191-199.
26. Almolda B, Gonzalez B, Castellano B, (2011) Antigen presentation in EAE: role of microglia, macrophages and dendritic cells. Front Biosci 16: 1157-1171.
27. Fletcher JM, Lalor SJ, Sweeney CM, Tubridy N, Mills KH, (2010) T cells in multiple sclerosis and experimental autoimmune encephalomyelitis. Clin Exp Immunol 162: 1-11.
28. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100: 655-669.
29. Miller SA, Weinmann AS, (2009) Common themes emerge in the transcriptional control of T helper and developmental cell fate decisions regulated by the T-box, GATA and ROR families. Immunology 126: 306-315.
30. Murphy AC, Lalor SJ, Lynch MA, Mills KH, (2010) Infiltration of Th1 and Th17 cells and activation of microglia in the CNS during the course of experimental autoimmune encephalomyelitis. Brain Behav Immun 24: 641-651.
31. O'Connor RA, Prendergast CT, Sabatos CA, Lau CW, Leech MD, et al. (2008) Cutting edge: Th1 cells facilitate the entry of Th17 cells to the central nervous system during experimental autoimmune encephalomyelitis. J Immunol 181: 3750-3754.
32. Koenders MI, van den Berg WB, (2010) Translational mini-review series on Th17 cells: are T helper 17 cells really pathogenic in autoimmunity? Clin Exp Immunol 159: 131-136.
33. Ke Y, Liu K, Huang GQ, Cui Y, Kaplan HJ, et al. (2009) Anti-inflammatory role of IL-17 in experimental autoimmune uveitis. J Immunol 182: 3183-3190.
34. Haak S, Croxford AL, Kreymborg K, Heppner FL, Pouly S, et al. (2009) IL-17A and IL-17F do not contribute vitally to autoimmune neuro-inflammation in mice. J Clin Invest 119: 61-69.
35. McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, et al. (2007) TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8: 1390-1397.
36. Xiao BG, Bai XF, Zhang GX, Link H, (1998) Suppression of acute and protracted-relapsing experimental allergic encephalomyelitis by nasal administration of low-dose IL-10 in rats. J Neuroimmunol 84: 230-237.
37. Vollmer TL, Liu R, Price M, Rhodes S, La Cava A, et al. (2005) Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 174: 2696-2701.
38. Piao WH, Jee YH, Liu RL, Coons SW, Kala M, et al. (2008) IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis. Scand J Immunol 67: 37-46.
39. Liu R, Bai Y, Vollmer TL, Bai XF, Jee Y, et al. (2008) IL-21 receptor expression determines the temporal phases of experimental autoimmune encephalomyelitis. Exp Neurol 211: 14-24.
40. Leonard WJ, Zeng R, Spolski R, (2008) Interleukin 21: a cytokine/cytokine receptor system that has come of age. J Leukoc Biol 84: 348-356.
41. Brandt K, Bulfone-Paus S, Foster DC, Ruckert R, (2003) Interleukin-21 inhibits dendritic cell activation and maturation. Blood 102: 4090-4098.
42. Brandt K, Bulfone-Paus S, Jenckel A, Foster DC, Paus R, et al. (2003) Interleukin-21 inhibits dendritic cell-mediated T cell activation and induction of contact hypersensitivity in vivo. J Invest Dermatol 121: 1379-1382.
43. Korn T, Reddy J, Gao W, Bettelli E, Awasthi A, et al. (2007) Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat Med 13: 423-431.
44. Kohm AP, Carpentier PA, Anger HA, Miller SD, (2002) Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J Immunol 169: 4712-4716.
45. Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, et al. (2004) IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16: 249-256.
46. Pender MP, Nguyen KB, McCombe PA, Kerr JF, (1991) Apoptosis in the nervous system in experimental allergic encephalomyelitis. J Neurol Sci 104: 81-87.
47. Pender MP, McCombe PA, Yoong G, Nguyen KB, (1992) Apoptosis of alpha beta T lymphocytes in the nervous system in experimental autoimmune encephalomyelitis: its possible implications for recovery and acquired tolerance. J Autoimmun 5: 401-410.
48. Schmied M, Breitschopf H, Gold R, Zischler H, Rothe G, et al. (1993) Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am J Pathol 143: 446-452.
49. McCombe PA, Nickson I, Tabi Z, Pender MP, (1996) Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein. J Neurol Sci 139: 1-6.
50. Moline-Velazquez V, Cuervo H, Vila-Del Sol V, Ortega MC, Clemente D, et al. (2011) Myeloid-Derived Suppressor Cells Limit the Inflammation by Promoting T Lymphocyte Apoptosis in the Spinal Cord of a Murine Model of Multiple Sclerosis. Brain Pathol.
51. Gabrilovich DI, Nagaraj S, (2009) Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9: 162-174.
52. Zhou L, Chong MM, Littman DR, (2009) Plasticity of CD4+ T cell lineage differentiation. Immunity 30: 646-655.
53. O'Shea JJ, Paul WE, (2010) Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327: 1098-1102.